(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | (Q3)May 31, 2022 | (Q2)Feb 28, 2022 | (Q1)Nov 30, 2021 | (FY)Aug 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -228.08%-720.48K | -84.04%-1.65M | -1.17M | 18.10%-3.75M | -1,092.09%-4.57M | -3.08M | 425.25%562.51K | -3,507.18%-899.23K | -13,107.21%-1.16M | -383.71K |
Net income from continuing operations | -296.43%-2.43M | -67.66%-1.8M | ---2.19M | 53.83%-4.45M | -998.06%-9.64M | ---7.12M | 686.21%1.24M | -2,027.23%-1.07M | -1,800.05%-2.68M | ---878.04K |
Operating gains losses | ---- | ---- | ---- | 1,459.40%7.74K | -102.54%-569 | --0 | ---71.83K | --37.67K | --33.59K | --22.4K |
Depreciation and amortization | --67.1K | --59.3K | --56.45K | -12.17%135.88K | 103,030.00%154.7K | --113.66K | ---- | ---- | ---- | --150 |
Asset impairment expenditure | --0 | ---- | ---- | --0 | 5,595.51%2.13M | ---- | ---- | ---- | ---- | --37.36K |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---53.35K |
Remuneration paid in stock | 3,412.15%937.99K | 73.03%280.89K | --457.16K | 68.64%1.08M | 96.14%641.55K | --359.99K | --26.71K | --162.34K | --92.52K | --327.08K |
Other non cashItems | 100.70%4.46K | 141.67%6.65K | --8.83K | -100.03%-1.05K | --3.18M | --1.96M | ---636.66K | ---15.97K | --1.87M | ---- |
Change In working capital | 2,223.62%698.1K | -1,128.63%-206.1K | --498.2K | 49.85%-518.66K | -743.62%-1.03M | ---522.32K | -186.69%-32.87K | -103.68%-16.78K | -13,826.72%-462.23K | --160.69K |
-Change in receivables | 727.44%501.6K | -5,892.30%-556.41K | ---27.23K | 32.57%-325.25K | ---482.37K | ---353.75K | -1,804.79%-79.94K | --9.61K | ---58.28K | --0 |
-Change in inventory | 48.23%299.23K | 134.99%162.58K | ---127.48K | 129.82%288.71K | ---968.04K | ---675.53K | --201.87K | ---464.58K | ---29.8K | --0 |
-Change in prepaid assets | -45.35%106.37K | -147.00%-32.5K | --247.01K | -124.61%-830.15K | -790.57%-369.6K | ---172.7K | 19,562.80%194.63K | --69.15K | ---460.68K | ---41.5K |
-Change in payables and accrued expense | -4,481.71%-277.51K | 479.77%107.09K | --353.13K | -11.50%324.58K | 81.39%366.76K | --267.82K | -114.05%-6.06K | 324.27%18.47K | 2,706.93%86.52K | --202.19K |
-Change in other working capital | 119.92%68.4K | --113.14K | --52.78K | -94.41%23.44K | --419.05K | --411.84K | ---343.37K | ---- | ---- | ---- |
Interest paid (cash flow from operating activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.56K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -228.08%-720.48K | -84.04%-1.65M | ---1.17M | 18.10%-3.75M | -1,092.09%-4.57M | ---3.08M | 425.25%562.51K | -3,507.18%-899.23K | -13,107.21%-1.16M | ---383.71K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -117.96%-62.84K | 119.95%6.4K | 8.42K | 107.78%18.69K | -6.20%-240.07K | -290.3K | 350K | -139.71%-32.1K | -78.45%-267.67K | -226.05K |
Net PPE purchase and sale | -172.67%-100.87K | 1.49%-31.62K | ---29.61K | 62.82%-38.35K | -3,722.83%-103.14K | ---143.3K | --138.81K | ---32.1K | ---66.55K | ---2.7K |
Net business purchase and sale | ---- | ---- | ---- | --0 | 27.12%-147K | ---- | ---- | --0 | --12.6K | ---201.7K |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | 83.33%-25K | ---21.65K |
Net other investing changes | -80.87%38.03K | --38.03K | --38.03K | 466.57%57.04K | --10.07K | --0 | --198.79K | --0 | ---188.73K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -117.96%-62.84K | 119.95%6.4K | --8.42K | 107.78%18.69K | -6.20%-240.07K | ---290.3K | --350K | -139.71%-32.1K | -78.45%-267.67K | ---226.05K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 97.55%-77.3K | -95.39%-54.28K | 5.4M | -104.43%-380.23K | 147.22%8.58M | 8.62M | -217.39%-3.15M | -27.78K | 3.15M | 3.47M |
Net issuance payments of debt | -752.70%-77.3K | -177.43%-77.07K | ---77.07K | -9.71%-195.38K | ---178.08K | ---143.95K | --11.84K | ---27.78K | ---18.19K | --0 |
Net common stock issuance | --0 | --4.04K | --4.92M | --0 | 26.07%3.35M | --3.35M | -217.83%-3.16M | --0 | --3.16M | --2.66M |
Proceeds from stock option exercised by employees | --0 | --18.75K | --563.66K | --43.72K | --0 | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | -104.22%-228.58K | 563.03%5.41M | ---- | ---- | ---- | ---- | --816.65K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 97.55%-77.3K | -95.39%-54.28K | --5.4M | -104.43%-380.23K | 147.22%8.58M | --8.62M | -217.39%-3.15M | ---27.78K | --3.15M | --3.47M |
Net cash flow | ||||||||||
Beginning cash position | 37.96%5.22M | 46.00%6.93M | --2.69M | 124.72%6.79M | 1,784.55%3.02M | --2.33M | 6,475.73%3.79M | 285,732.89%4.74M | 1,784.55%3.02M | --160.42K |
Current changes in cash | 61.58%-860.62K | -77.54%-1.7M | --4.24M | -208.94%-4.11M | 31.71%3.77M | --5.25M | -189.15%-2.24M | -1,815.43%-959.11K | 1,184.43%1.72M | --2.86M |
Effect of exchange rate changes | --5.54K | ---2.05K | ---383 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
End cash Position | 87.20%4.37M | 37.96%5.22M | --6.93M | -60.46%2.69M | 124.72%6.79M | --6.79M | -9.22%2.33M | 6,475.73%3.79M | 285,732.89%4.74M | --3.02M |
Free cash from | -227.02%-821.35K | -81.09%-1.69M | ---1.2M | 20.02%-3.78M | -1,124.61%-4.73M | ---3.22M | 473.90%646.65K | -3,635.94%-931.33K | -13,866.87%-1.22M | ---386.41K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.